This series features outstanding science from expert investigators alternating with Advance RI-CTR Pilot Projects awardees sharing their early research. Seminars are held virtually on the second Thursday of each month.
We're excited to announce the second RFA for the Advance-R Program. We are now accepting applications for an internal study section opportunity for those looking to submit applications for their first R Award (or similar awards). Scholars will also attend didactic sessions on topics related to R-award preparation. This program is open to those submitting for the first time, and those resubmitting applications for funding.
Advance RI-CTR is very pleased to announce that experienced healthcare leader Anya Rader Wallack, PhD, has joined our leadership team as Administrative Director.
The call for applications is now open for the 2023 Advance-K Scholar Career Development Program from Advance-CTR and the Division of Biology and Medicine at Brown University. Learn what it takes to win an NIH K award and jumpstart your research career.
The Advance-CTR Distinguished Clinical and Translational Research Seminar Series showcases clinical and translational research from across Rhode Island. This series features outstanding science from expert investigators across the translational spectrum. Seminars are held virtually on the second Thursday of each month.
Amy Stamates, PhD, has been awarded a 5-year K01 Mentored Research Scientist Development Award from the National Institute of Alcohol Abuse and Alcoholism
The Advance-CTR Distinguished Clinical and Translational Research Seminar Series showcases clinical and translational research from across Rhode Island. This series features outstanding science from expert investigators across the translational spectrum. Seminars are held virtually on the second Thursday of each month.
New federal grants totaling $1.4 million are supporting a partnership between Brown, Progreso Latino, the Rhode Island Quality Institute and others to address barriers to testing and vaccination among high-risk populations.